Addex Therapeutics Ltd (ADXN)
Total Valuation
ADXN has a market cap or net worth of $9.20 million. The enterprise value is $3.94 million.
Market Cap | 9.20M |
Enterprise Value | 3.94M |
Important Dates
The last earnings date was Wednesday, November 29, 2023, before market open.
Earnings Date | Nov 29, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
ADXN has 1.52 million shares outstanding.
Shares Outstanding | 1.52M |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 7.40% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.11 |
Forward PS | n/a |
PB Ratio | 1.96 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.76 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.08.
Current Ratio | 2.97 |
Quick Ratio | 2.56 |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -33.41 |
Financial Efficiency
Return on equity (ROE) is -238.30% and return on invested capital (ROIC) is -260.03%.
Return on Equity (ROE) | -238.30% |
Return on Assets (ROA) | -147.80% |
Return on Capital (ROIC) | -260.03% |
Revenue Per Employee | $93,393 |
Profits Per Employee | -$514,085 |
Employee Count | 24 |
Asset Turnover | 0.27 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.98% in the last 52 weeks. The beta is 1.61, so ADXN's price volatility has been higher than the market average.
Beta (1Y) | 1.61 |
52-Week Price Change | -51.98% |
50-Day Moving Average | 5.87 |
200-Day Moving Average | 10.98 |
Relative Strength Index (RSI) | 56.84 |
Average Volume (30 Days) | 8,794 |
Short Selling Information
Short Interest | 3,627 |
Short Previous Month | 4,155 |
Short % of Shares Out | 0.05% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.42 |
Income Statement
In the last 12 months, ADXN had revenue of $2.24 million and -$12.34 million in losses. Loss per share was -$0.18.
Revenue | 2.24M |
Gross Profit | 2.45M |
Operating Income | -13.18M |
Pretax Income | -13.49M |
Net Income | -12.34M |
EBITDA | -12.73M |
EBIT | -13.09M |
Loss Per Share | -$0.18 |
Balance Sheet
The company has $5.65 million in cash and $384,118 in debt, giving a net cash position of $5.26 million or $3.46 per share.
Cash & Cash Equivalents | 5.65M |
Total Debt | 384,118 |
Net Cash | 5.26M |
Net Cash Per Share | $3.46 |
Equity / Book Value | 4.69M |
Book Value Per Share | 3.08 |
Working Capital | 4.53M |
Cash Flow
In the last 12 months, operating cash flow was -$12.40 million and capital expenditures -$6,698, giving a free cash flow of -$12.41 million.
Operating Cash Flow | -12.40M |
Capital Expenditures | -6,698 |
Free Cash Flow | -12.41M |
FCF Per Share | -$19.88 |
Margins
Gross margin is 109.30%, with operating and profit margins of -588.21% and -550.45%.
Gross Margin | 109.30% |
Operating Margin | -588.21% |
Pretax Margin | -601.65% |
Profit Margin | -550.45% |
EBITDA Margin | -568.15% |
EBIT Margin | -584.17% |
FCF Margin | -553.73% |
Dividends & Yields
ADXN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -134.07% |
FCF Yield | -134.87% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -97.79% |
Shareholder Yield | -97.79% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | 19.20% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.
Last Split Date | Oct 23, 2023 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
ADXN has an Altman Z-Score of -84.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -84.31 |
Piotroski F-Score | 3 |